IRISIGHT
Live / Registered — Registered (as of 29 Oct 2024)
What this means for you
Registered since 29 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97381602
- Registration number
- 7552857
- Mark type
- Stylized text
- Filed
- 26 Apr 2022
- Published for opposition
- 23 May 2023
- Registered
- 29 Oct 2024
- Attorney of record
- Mark I. Koffsky
Goods and services
- Class 042 — Scientific and technological services: Scientific laboratory services in the field of genomics, namely, genetic sequencing, analysis and diagnosis of biological samples for analyzing, classifying, interpreting and diagnosing genetic data; Platform as a Services (PAAS) featuring computer software platforms for analyzing, classifying, interpreting and diagnosing genetic data; Platform as a Services (PAAS) featuring computer software platforms that provide a diagnostic report based on genetic analysis; Platform as a Services (PAAS) featuring computer software platforms for analyzing genetic data and providing medical information to healthcare professionals; All of the above-mentioned services in the field of reproductive health and reproductive medicine for analyzing, classifying, interpreting and diagnosing genetic data
- Class 044 — Medical, beauty and agricultural services: Genetic testing for medical purposes; Consulting services in the field of genetic testing for medical purposes; Medical and health services relating to DNA, genetics, genetic testing and genetic sequencing in the field of prenatal analysis; Providing medical information via medical reports, namely, diagnostic reports based on genetic analysis; Providing medical information to healthcare professionals on genetic variants diagnostics; Providing medical information via a website featuring information on patient genetic data for diagnosis purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical laboratory services for the analysis of samples taken from patients, namely, analysis of biological sample and genetic sequencing for diagnostic and treatment purposes; Laboratory testing services, namely, genetic testing in the field of oncology for analyzing, classifying, interpreting and diagnosing genetic data for medical diagnostic and treatment purposes; All of the above-mentioned services in the field of reproductive health and reproductive medicine
Owner
- Variantyx Inc., Farmingham, MA, US
- Variantyx Inc., Farmingham, MA, US
- Variantyx Inc., Farmingham, MA, US
Prosecution history
- 29 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 21 Sept 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Sept 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jun 2024 — USE AMENDMENT FILED
- 15 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jun 2024 — TEAS STATEMENT OF USE RECEIVED
- 30 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Dec 2023 — POST PUBLICATION AMENDMENT - ENTERED
- 18 Dec 2023 — ASSIGNED TO PETITION STAFF
- 24 Nov 2023 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 10 Nov 2023 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 21 Jun 2023 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 23 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED